Skip to main content
Clinical Trials/KCT0005991
KCT0005991
Completed
未知

Prospective, multicenter, pilot study to evaluate the effectiveness of biomarkers for early diagnosis of acute rejection in de novo renal transplant recipients

Kyungpook National University Hospital0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyungpook National University Hospital
Enrollment
40
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 31, 2020
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Newly kidney transplant recipient
  • 2\) Aged from 18 to 75
  • 3\) High risk of acute rejection (one or more of the following is satisfied)
  • HLA mismatch \=5
  • Pretransplant panel reactive antibody \=30%
  • Pretransplant desensitization
  • Positive for direct cross match
  • Extended criteria deceased donor kidney transplantation
  • 4\) Induction immunosuppression using anti\-thymocyte globulin or basiliximab,and maintenance immunosuppression by tacrolimus, mycophenolic acid and steroid

Exclusion Criteria

  • 1\) Active infection
  • 2\) HIV, HCV infection
  • 3\) Comorbid untreatable ischemic heart disease
  • 4\) Abnormality of hematologic exam (hemoglobin \<7\.0g/dL, leukocyte count \<2,500/mm3, absolute neutrophil count \<1,500/mm3, platelet count \<75,000/mm3\)
  • 5\) Pregnant
  • 6\) Multiorgan trasnplant
  • 7\) History of malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials